Seeking men and women within 24 months of diagnosis with Amyotrophic Lateral Sclerosis (ALS) for a study of an investigational drug.
Participants in this study will have up to 8 clinic visits and at least 9 home visits over a year. Participants may need to conduct pulmonary tests using a home device and smartphone app.
What we're hoping for
We are studying whether the investigational drug is safe and effective in preventing muscle weakness and fatigue associated with Amyotrophic Lateral Sclerosis (ALS)
ClinicalTrials.gov Identifier: NCT04944784